Plasma levels of metalloproteinase-9 are elevated in patients with chronic autoimmune urticaria

British Journal of Dermatology

Volumn 161, Issue 3, 2009, Pages 712-714

  Antiga, E ^a   Volpi, W ^a   Del Bianco, E ^a   Fabbri, P ^a   Caproni, M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Chronic autoimmune urticaria; Chronic idiopathic urticaria; Matrix metalloproteinase 2; Matrix metalloproteinase 9; Tissue inhibitor of metalloproteinases 1; Tissue inhibitor of metalloproteinases 2

Indexed keywords

GELATINASE A; GELATINASE B; METALLOPROTEINASE; METALLOPROTEINASE 9; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ADULT; AUTOIMMUNE SKIN DISEASE; BLOOD LEVEL; BLOOD SAMPLING; CHRONIC URTICARIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; LETTER; MALE; PRIORITY JOURNAL;

ADULT; AUTOIMMUNE DISEASES; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; URTICARIA; YOUNG ADULT;

EID: 69149084506     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09368.x     Document Type: Letter

References (10)

1. Sabroe RA, Greaves MW. Chronic idiopathic urticaria with functional autoantibodies: 12 years on. Br J Dermatol 2006 154 : 813 819.
2. Ram M, Sherer Y, Shoenfeld Y. Matrix metalloproteinase-9 and autoimmune diseases. J Clin Immunol 2006 26 : 299 307.
3. Khorramizadeh MR, Falak R, Pezeshki M et al. Dermal wound fibroblasts and matrix metalloproteinases (MMPs): their possible role in allergic contact dermatitis. Iran J Allergy Asthma Immunol 2004 3 : 7 11.
4. van de Steen PE, Proost P, Wuyts A et al. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4 and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 2000 96 : 2673 2681.
5. Caproni M, Giomi B, Melani L et al. Cellular infiltrate and related cytokines, chemokines, chemokine receptors and adhesion molecules in chronic autoimmune urticaria: comparison between spontaneous and autologous serum skin test induced wheal. Int J Immunopathol Pharmacol 2006 19 : 507 515.
6. Matrisian L. Metalloproteinases and their inhibitors in matrix remodelling. Trends Genet 1990 6 : 121 125.
7. Caproni M, Volpi W, Giomi B et al. Chronic idiopathic urticaria and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects. Acta Derm Venereol (Stockh) 2004 84 : 288 290.
8. Breneman D, Bronsky AK, Bruce S. Cetirizine and astemisone therapy for chronic urticaria: a double-blind, placebo-controlled, comparative trial. J Am Acad Dermatol 1995 33 : 192 198.
9. Robak E, Wierzbowska A, Chmiela M et al. Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with systemic lupus erythematosus. Mediators Inflamm 2006 1 : 17898.
10. Kessel A, Bishara R, Amital A et al. Increased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticaria. Clin Exp Allergy 2005 35 : 221 225.